
Marla Shapiro
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Fezolinetant treatment for hot flashes associated with menopause: A plain language summary of the DAYLIGHT study.
Journal: Women's health (London, England)
Published: April 03, 2026
Obesity: assessment and treatment across the care continuum.
Journal: Annals of medicine
Published: June 26, 2025
Totality of evidence refutes neoplasm risk with fezolinetant.
Journal: Lancet (London, England)
Published: October 31, 2023
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 26, 2022
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.
Journal: Lancet (London, England)
Published: April 26, 2022
A Master Class in Family Doctor Leadership: Evaluating an Innovative Program.
Journal: Family medicine
Published: September 29, 2021
Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.
Journal: Sexual medicine
Published: August 26, 2021
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?
Journal: Canadian family physician Medecin de famille canadien
Published: September 14, 2019
An individualized approach to the management of vaginal atrophy in Latin America.
Journal: Menopause (New York, N.Y.)
Published: June 13, 2019
Do social determinants of health make a difference in the age at natural menopause in Canada?
Journal: Menopause (New York, N.Y.)
Published: December 07, 2017
Last Updated: 09/26/2026